AD - Atopisk eksem
Artikel
Patient-Reported Outcome Measures (PROMs) in Dermatology
Interview by DermTalks
DermTalks is a project led with a board of dermatologists and intended to address current challenges, data gaps and emerging trends in dermatology across North-European countries.
Speaker: Prof. Mette Deleuran, Associate Professor and Chair of the Department of Dermatology and Venereology, Aarhus University Hospital, Denmark.
Sleep and QOL: the full impact on patients coping with the burden of AD
Understanding the full scope of AD—the unseen burden on patients.
Atopic dermatitis pathophysiology: type 2 inflammation & cytokines
Beneath the skin of patients with AD—type 2 inflammation and the cytokines involved.
Advancing Treatment for Uncontrolled AD and PN: New Approaches
As we continue to advance in our understanding and treatment capabilities, our response to uncontrolled AD and PN becomes more effective, paving the way for a future where patients can lead healthier, more comfortable lives8.
Underneath the Skin: Hidden Challenges of Uncontrolled AD and PN
What are the hidden challenges of living with uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)?
Leave site modal
Du er ved at forlade campus.sanofi/dk. Sanofi er ikke ansvarlig for indholdet af dette eksterne websted.
Arbejder du inden for sundhedsvæsenet?
Arbejder du inden for sundhedsvæsenet?
Denne hjemmeside indeholder kun information, der er rettet mod sundhedspersoner. Bekræft venligst nedenfor for at modtage information, film, podcasts og andet materiale.